Chlorion Pharma is a start-up biotechnology company developing novel therapeutics for pain and epilepsy that quell neuronal hyperactivity by correct aberrant chloride homeostasis. The company was spun-out of Laval University in 2004 and since this time has raised over $12M in venture financing. As of January 2011 Chlorion's lead KCC2 modulator, CLP657, is in full pre-clinical development and should qualify as an IND by Q3 2011.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.chlorion.com
- Keywords
- Moffett Field.
Chlorion Pharma Questions
Chlorion Pharma's website is http://www.chlorion.com
Chlorion Pharma's LinkedIn profile is https://ca.linkedin.com/company/chlorion-pharma
Chlorion Pharma's industry is
Pharmaceutical Manufacturing
Chlorion Pharma's top competitors are
Autolus Therapeutics,
Aspect Biosystems,
Quell Therapeutics,
Karuna Therapeutics,
Nasa Genelab.
Chlorion Pharma's categories are Pharmaceutical Manufacturing
